Bukwang Pharmaceutical IND: Preliminary earnings (consolidated)
This is a preliminary earnings filing in which Bukwang Pharmaceutical shares an early look at its consolidated results, meaning the combined figures for the company and its subsidiaries, ahead of the full financial report. It usually tells shareholders roughly how sales and profits came in, though the numbers are unaudited and may change when the final report is released. Bukwang Pharmaceutical IND filed this on Oct 23, 2026.
Predicted impact: Medium
Preliminary consolidated results for company with 215B won revenue; no figures given to judge surprise.
Company filing